Alexei A. Terent’ev

Dr. Alexei A. Terent’ev

Federal Research Center of Problem of Chemical Physics and Medicinal Chemistry RAS, Chernogolovka, Moskovskaya Oblast’, Russia
+2
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EGEva Grönroos
Eva Grönroos
ATAlexei A. Terent’ev
Alexei A. Terent’ev
TPTanel Punga
Tanel Punga
JEJohan Ericsson
Johan Ericsson
The tumor suppressor p53 regulates cell-cycle progression and apoptosis in response to genotoxic stress, and inactivation of p53 is a common feature of cancer cells. The levels and activity of p53 are tightly regulated by posttranslational modifications, including phosphorylation, ubiquitination, and acetylation. Here, we demonstrate that the transcription factor Yin Yang 1 (YY1) interacts with p53 and inhibits its transcriptional activity. We show that YY1 disrupts the interaction between p53 and the coactivator p300 and that expression of YY1 blocks p300-dependent acetylation and stabilization of p53. Furthermore, expression of YY1 inhibits the accumulation of p53 and the induction of p53 target genes in response to genotoxic stress. YY1 also interacts with Mdm2 and the expression of YY1 promotes the assembly of the p53–Mdm2 complex. Consequently, YY1 enhances Mdm2-mediated ubiquitination of p53. Inactivation of endogenous YY1 enhances the accumulation of p53 as well as the expression of p53 target genes in response to DNA damage, and it sensitizes cells to DNA damage-induced apoptosis. Hence, our results demonstrate that YY1 regulates the transcriptional activity, acetylation, ubiquitination, and stability of p53 by inhibiting its interaction with the coactivator p300 and by enhancing its interaction with the negative regulator Mdm2. YY1 may, therefore, be an important negative regulator of the p53 tumor suppressor in response to genotoxic stress.

1 July 2003 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
KKKeiko Kurisaki
Keiko Kurisaki
AKAkira Kurisaki
Akira Kurisaki
UVUlrich Valcourt
Ulrich Valcourt
ATAlexei A. Terent’ev
Alexei A. Terent’ev
KPKaterina Pardali
Katerina Pardali
AMAristidis Moustakas
Aristidis Moustakas
Smad proteins transduce transforming growth factor β (TGF-β) and bone morphogenetic protein (BMP) signals that regulate cell growth and differentiation. We have identified YY1, a transcription factor that positively or negatively regulates transcription of many genes, as a novel Smad-interacting protein. YY1 represses the induction of immediate-early genes to TGF-β and BMP, such as the plasminogen activator inhibitor 1 gene (PAI-1) and the inhibitor of differentiation/inhibitor of DNA binding 1 gene (Id-1). YY1 inhibits binding of Smads to their cognate DNA elements in vitro and blocks Smad recruitment to the Smad-binding element-rich region of the PAI-1 promoter in vivo. YY1 interacts with the conserved N-terminal Mad homology 1 domain of Smad4 and to a lesser extent with Smad1, Smad2, and Smad3. The YY1 zinc finger domain mediates the association with Smads and is necessary for the repressive effect of YY1 on Smad transcriptional activity. Moreover, downregulation of endogenous YY1 by antisense and small interfering RNA strategies results in enhanced transcriptional responses to TGF-β or BMP. Ectopic expression of YY1 inhibits, while knockdown of endogenous YY1 enhances, TGF-β- and BMP-induced cell differentiation. In contrast, overexpression or knockdown of YY1 does not affect growth inhibition induced by TGF-β or BMP. Accordingly, YY1 does not interfere with the regulation of immediate-early genes involved in the TGF-β growth-inhibitory response, the cell cycle inhibitors p15 and p21, and the proto-oncogene c-myc. In conclusion, YY1 represses Smad transcriptional activities in a gene-specific manner and thus regulates cell differentiation induced by TGF-β superfamily pathways.

1 March 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GMGalina F. Makhaeva
Galina F. Makhaeva
NBNatalia Boltneva
Natalia Boltneva
SLSofya Lushchekina
Sofya Lushchekina
OSOlga G. Serebryakova
Olga G. Serebryakova
TSTatyana S. Stupina
Tatyana S. Stupina
Rudy RichardsonRudy Richardson
Rudy Richardson

24 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
IRIgor Rzhepakovsky
Igor Rzhepakovsky
DADavid A Areshidze
David A Areshidze
SASvetlana S. Avanesyan
Svetlana S. Avanesyan
WGWolf D. Grimm
Wolf D. Grimm
NFNatalya V. Filatova
Natalya V. Filatova
SPSergei Piskov
Sergei Piskov
Chlorophytum genus has been extensively studied due to its diverse biological activities. We evaluated the methanolic extract of leaves of Chlorophytum comosum (Green type) (Thunb.) Jacques, the species that is less studied compared to C. borivilianum. The aim was to identify phytoconstituents of the methanolic extract of leaves of C. comosum and biological properties of its different fractions. Water fraction was analyzed with matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Nineteen compounds belonging to different chemical classes were identified in the methanolic extract of leaves of C. comosum (Green type) (Thunb.) Jacques. In addition to several fatty acids, isoprenoid and steroid compounds were found among the most abundant constituents. One of the identified compounds, 4′-methylphenyl-1C-sulfonyl-β-d-galactoside, was not detected earlier in Chlorophytum extracts. The water fraction was toxic to HeLa cells but not to Vero cells. Our data demonstrate that methanolic extract of leaves of C. comosum can be a valuable source of bioactive constituents. The water fraction of the extract exhibited promising antitumor potential based on a high ratio of HeLa vs. Vero cytotoxicity.

25 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
TKTatiana S. Kokovina
Tatiana S. Kokovina
SGSvyatoslav Gadomsky
Svyatoslav Gadomsky
ATAlexei A. Terent’ev
Alexei A. Terent’ev
NSNataliya Sanina
Nataliya Sanina
The main purpose of the study was the development of a new method for synthesis of 1,3,4-thiadiazol-2-amine derivatives in a one-pot manner using the reaction between a thiosemicarbazide and carboxylic acid without toxic additives such as POCl3 or SOCl2. The reaction was investigated in the presence of polyphosphate ester (PPE). It was found that, in the presence of PPE, the reaction between the thiosemicarbazide and carboxylic acid proceeds in one-pot through three steps with the formation of corresponding 2-amino-1,3,4-thiadiazole. Using the developed approach five, 2-amino-1,3,4-thiadiazoles were synthesized. The structures of all compounds were proven by mass spectrometry, IR, and NMR spectroscopies.

1 June 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GMGALINA Makhaeva
GALINA Makhaeva
SLSofya Lushchekina
Sofya Lushchekina
NBNatalia Boltneva
Natalia Boltneva
OSOlga G. Serebryakova
Olga G. Serebryakova
NKNadezhda Kovaleva
Nadezhda Kovaleva
Rudy RichardsonRudy Richardson
Rudy Richardson